Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Corporación América Airports enters the week heading into a November 18 earnings date with a quietly notable tension: short sellers have been adding positions at pace while options traders have swung in the opposite direction, leaning more bullish than they have in months.
The short interest story is the most active thing in the data right now. Shorts have climbed 34% over the past month to 1.99 million shares, representing 1.2% of the free float. That remains a low absolute level, but the direction of travel is sharp. The weekly build of 13.2% is the largest in recent months. The official FINRA fortnightly figure from September 30 put shares short at 1.92 million, with days-to-cover at 5.56, so any acceleration would not be quickly unwound. Borrowing costs have risen 34% over the past week to 0.62%, though they remain cheap in absolute terms. Availability, however, is very loose: at 591% of short interest, lenders have far more stock available than has been borrowed, and that reading is well above the 52-week floor of 474%. There is no squeeze pressure in the lending market.
Options tell a different story. The put/call ratio has dropped sharply to 0.41, almost a full standard deviation below its 20-day average of 0.58. That shift has been dramatic: the PCR was running above 0.80 throughout September, suggesting hedging demand that has now largely unwound. Call buyers have moved back into the driving seat. The 52-week PCR range runs from 0.12 to 1.34, so the current reading is not extreme, but the directional change over three weeks is striking given that short interest has been moving the other way.
The Street remains constructive. Three analysts carry buy-equivalent ratings and the consensus price target of $32.40 represents roughly 32% upside to Tuesday's close of $24.48. JP Morgan, the most active follower, trimmed its target to $32 from $33 in mid-September while holding its Overweight rating, a modest downward adjustment rather than a change of view. Goldman Sachs sits at Neutral with a $28.50 target, the only dissenting voice. Valuation looks undemanding: the EV/EBITDA multiple is 5.5 times, and it has edged lower over the past month. The price-to-earnings ratio of 11.2 times is similarly modest. Factor scores are mixed: the EV/EBIT rank at the 87th percentile signals value appeal, but the forward earnings growth rank is weak at the 17th percentile, and the analyst recommendation differential score is near the bottom of the universe at just 5.
Ownership is heavily concentrated. Southern Cone Foundation controls 80.5% of shares, a stake that has not moved in the reported data. Helikon Investments, which filed a Schedule 13G last year disclosing an 8.46% passive stake, added modestly in the period through June, bringing its institutional holding to roughly 8.3% of shares. BlackRock added 177,000 shares in the quarter through September. None of these moves are aggressive, but the combination of a locked-up controlling shareholder and a handful of active managers means the tradeable float is thin, which amplifies the significance of even modest short-interest growth.
The recent earnings history is brief but worth noting. The August print produced a 1.2% one-day gain and a 7% five-day gain. Peer performance this week has been broadly negative: ENAV fell 5.5% and FRA dropped 4.6%, while ECOR3 climbed 5.7% against the trend. CAAP's own 3% weekly decline puts it roughly in line with the weaker end of the group. The November 18 print is the next hard date: with short interest building, options more call-heavy than at any point since late September, and a stock trading 32% below consensus targets, the gap between how short sellers and options traders are positioned is the thing to watch as that date approaches.
See the live data behind this article on ORTEX.
Open CAAP on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
